Archive - May 2018
Braeburn Resubmits New Drug Application for CAM2038 for Opioid Use Disorder
Pfizer Announces U.S. FDA Approves Xeljanz (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis
Dengue Fever: Millions Of Potential Cases Avoidable By Reducing Global Temperatures
Loxo, Bayer get quick FDA review for ‘precision’ cancer drug
TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
Pfizer nabs two FDA Breakthrough Therapy designations
Novo Nordisk oral diabetes drug outperforms Lilly rival
Differential Scanning Calorimetry Finds a Place in Manufacturing